DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Bipolar Disorder - Japan Drug Forecast and Market Analysis to 2024" report to their offering.
Bipolar Disorder - Japan Drug Forecast and Market Analysis to 2024 estimates that drug sales for bipolar disorder in Japan reached $373.4m during 2014, making it the second largest market within the 8MM. The market is expected to grow starting from 2020, driven by the saturation of generic erosion and the uptake of novel pipeline agents.
- Overview of Bipolar Disorder including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in Japan including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in Japan from 2014-2024.
- Analysis of the impact of key events as well the drivers and restraints affecting Japan Bipolar Disorder market.
Key Topics Covered:
1 Tables & Figures
3 Disease Overview
4 Disease Management
5 Competitive Assessment
6 Unmet Need and Opportunity
7 Pipeline Assessment
8 Market Outlook
For more information visit http://www.researchandmarkets.com/research/n5gs65/bipolar_disorder